Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Fidelity Biosciences, Devonshire Investors’ Technology Venture Fund Launch As F-Prime Capital Partners

by businesswire.com posted 4years ago 6035 views
Fidelity Biosciences announced today that it is joining with Devonshire Investors’ technology venture capital fund to become F-Prime Capital. F-Prime Capital will create a new, unified name for the venture capital funds of FMR LLC, the parent company of Fidelity Investments, and continue its 40-year history as an active global investor in life sciences, healthcare and technology.